Have a personal or library account? Click to login
The Burden of Infections with Extended Spectrum Beta-Lactamase-Producing Pathogen on Home Health Care Services Cover

The Burden of Infections with Extended Spectrum Beta-Lactamase-Producing Pathogen on Home Health Care Services

Open Access
|Feb 2026

References

  1. Antibiotic resistance threats in the United States, 2019. CDC, US; 2019.
  2. Somily AM, Habib HA, Absar MM, et al.: ESBL-producing Escherichia coli and Klebsiella pneumoniae at atertiary care hospital in Saudi Arabia. The Journal of Infection in Developing Countries. 2014, 8:1129–1136. https://doi.org/10.3855/jidc.4292 PMid:25212077
  3. Aldrazi FA, Rabaan AA, Alsuliman SA, et al.: ESBL expression and antibiotic resistance patterns in a hospital in Saudi Arabia: Do healthcare staff have the whole picture?. Journal of Infection and Public Health. 2020,13:759–766. https://doi.org/10.1016/j.jiph.2019.12.001 PMid:31901487
  4. Alqasim A, Abu Jaffal A, Alyousef AA: Prevalence of Multidrug Resistance and Extended-Spectrum β-Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia. Int JMicrobiol. 20182018.
  5. Paterson DL, Bonomo RA: Extended-spectrum β-lactamases: A clinical update. Clinical Microbiology Reviews. 2005, 18:657–686. https://doi.org/10.1128/CMR.18.4.657-686.2005 PMid:16223952 PMCid:PMC1265908
  6. Pitout JD, Laupland KB: Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infectious Diseases. 2008, 8:159–166. https://doi.org/10.1016/S1473-3099(08)70041-0 PMid:18291338
  7. Harris M: Challenges of Treating Extended-Spectrum Beta-Lactamase in Long-Term Care. Advances in Family Practice Nursing. 2020, 2:11–20. https://doi.org/10.1016/j.yfpn.2019.12.002
  8. Shamsrizi P, Gladstone BP, Carrara E, et al.: Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. BMJ Open. 2020, 10:030266. https://doi.org/10.1136/bmjopen-2019-030266 PMid:31964661 PMCid:PMC7044956
  9. Öztürk R, Murt A: Epidemiology of urological infections: a global burden. World Journal of Urology. 2020,38:2669–2679. https://doi.org/10.1007/s00345-019-03071-4 PMid:31925549
  10. Dhillon RHP, Clark J: ESBLs: A Clear and Present Danger?. Critical Care Research and Practice. 2012,2012:11. https://doi.org/10.1155/2012/625170 PMid:21766013 PMCid:PMC3135063
  11. Shawn H MacVane, Lindsay O Tuttle, David P Nicolau: Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014, 9:232–238. https://doi.org/10.1002/jhm.2157 PMid:24464783
  12. Tacconelli E, Mazzaferri F, de Smet AM, et al.: ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019, 25:807. https://doi.org/10.1016/j.cmi.2019.01.005 PMid:30708122
  13. Osthoff M, McGuinness SL, Wagen AZ, et al.: Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: Identification of risk factors and outcome predictors in an6 of 7Australian tertiary referral hospital. International Journal of Infectious Diseases. 2015, 34:79–83. https://doi.org/10.1016/j.ijid.2015.03.006 PMid:25769526
  14. Tumbarello M, Sanguinetti M, Montuori E, et al.: Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007, 51:1987–1994. https://doi.org/10.1128/AAC.01509-06 PMid:17387156 PMCid:PMC1891412
  15. Schwaber MJ, Carmeli Y: Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007, 60:913–920. https://doi.org/10.1093/jac/dkm318 PMid:17848376
  16. Hobbs JG, Ryan MK, Ritchie B, et al.: Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Devices (CHID) study. BMJ Open; 7. Epub ahead of print July 1. 2017, https://doi.org/10.1136/bmjopen-2017-016763 PMid:28760798 PMCid:PMC5642663
Language: English
Page range: 11 - 14
Submitted on: Feb 24, 2025
|
Accepted on: Dec 5, 2025
|
Published on: Feb 26, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 Amjad S. Al Seraya, Kholoud Abdulaziz Bin Haikel, published by Scientific Foundation SPIROSKI
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.